Milestone Scientific (MLSS) Cash Flow Statement

Click line-items for a historical chart and %

Net (loss) income
Depreciation expense	69.35K
Amortization of patents	53.02K
Amortization of debt discount
Common stock and options issued for compensation, consulting and vendor services	1.14M
Bad debt expense (decrease) increase
Increase in accounts receivable	-759.39K
Decrease (Increase) in inventories	-226K
Increase to advances to contract manufacturer
(Increase) Decrease to prepaid expenses and other current assets	27.7K
Decrease in other assets	0
Increase in accounts payable	169.39K
Decrease in accrued expenses
Net cash used in operating activities
Purchases of property and equipment	-14.95K
Payment for patents rights	-15.62K
Net cash used in investing activities
Proceeds from sale of stock options	0
Net cash provided by financing activities
NET DECREASE IN CASH AND CASH EQUIVALENTS
Cash and cash equivalents at beginning of period	4.19M
Cash and cash equivalents at end of period	2.32M
Interest paid

Entities mentioned with MLSS

View All Entities